A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/702 (2006.01) A23K 1/16 (2006.01) A61K 31/7016 (2006.01) A61P 1/00 (2006.01) A61P 1/16 (2006.01) A61P 3/02 (2006.01) A61P 37/08 (2006.01) A23L 1/30 (2006.01)
Patent
CA 2653805
To promote the growth of human beings or animals, prevent the onset of diarrhea and prevent or ameliorate various diseases, it is intended to provide a substance which has an effect of decreasing eosinophils in the intestinal tract and a feed containing the same as a feed additive. Namely, an intestinal eosionphil-suppressing composition which contains an .alpha.-linked galactooligosaccharide as the active ingredient. When added in an amount of from 0.01 to 10% by weight, in terms of the saccharide, to an animal feed, this composition is useful in providing an intestinal eosinophil-suppressing feed.
Pour promouvoir la croissance chez l'homme et l'animal, empêcher les diarrhées et prévenir et améliorer différentes maladies, l'invention propose une substance réduisant les éosinophiles présents dans l'intestin et un aliment la contenant sous forme d'additif alimentaire. L'invention porte donc sur une composition supprimant les éosinophiles intestinaux dont le principe actif est un galactooligosaccharide à liaison .alpha.. Quand ajoutée à raison de 0,01 à 10% en poids de saccharide, à un aliment pour animal, la composition a un effet suppresseur sur les éosinophiles intestinaux.
Fujita Koki
Isobe Yosuke
Ito Tetsuya
Saito Sanshiro
Sato Toshiro
Ensuiko Sugar Refining Co. Ltd.
Kyle C. Larry
LandOfFree
Intestinal eosinophil-suppressing composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intestinal eosinophil-suppressing composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intestinal eosinophil-suppressing composition will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1931605